Exchange: NASDAQ·Updated 04:34 PM EDT
LIMN logo

LIMN Liminatus Pharma Inc.

$4.19
$0.075
(1.79%)
Today
Closed $4.27
$0.08
(1.87%)
After Hours
Mkt Cap$5.63M
Vol18,527.00

About LIMN

Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.
59

Bullish Sentiment

How do you feel about LIMN?

Advertisement|Remove ads.